Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Preferred Stock Liabilities (2017 - 2023)

Historic Preferred Stock Liabilities for Q32 Bio (QTTB) over the last 3 years, with Q4 2023 value amounting to $111.4 million.

  • Q32 Bio's Preferred Stock Liabilities changed N/A to $111.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $111.4 million, marking a year-over-year change of. This contributed to the annual value of $111.4 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Q32 Bio's Preferred Stock Liabilities is $111.4 million.
  • Over the past 5 years, Q32 Bio's Preferred Stock Liabilities peaked at $111.4 million during Q4 2023, and registered a low of $111.4 million during Q4 2023.